medigraphic.com
ISSN 2992-8036 (Electronic)
ISSN 2306-4102 (Print)
Órgano Oficial del Colegio Mexicano de Ortopedia y Traumatología

2018, Number 4

<< Back Next >>

Acta Ortop Mex 2018; 32 (4)

Parathyroid carcinoma: diagnosis by a femur fracture

Domínguez-Gasca LG, Colín-González CG, Barroso-Gómez G, Arellano-Aguilar G, Domínguez-Carrillo LG, Aguirre-Trigueros J

Language: Spanish
References: 14
Page: 229-233
PDF size: 354.12 Kb.


ABSTRACT

Background: Carcinoma of the parathyroid gland (PC) described by De Quervain since 1909, it represents the least common neoplasm, with an incidence of 1,25/10,000,000 peoples. It has been reported approximately 1,000 cases of CP in world literature. There are two series in Mexico, one of eight patients and other with four cases. Because CP is functionally active, its early clinical behavior is similar to that of parathyroid benign neoplasms. Clinical case: A 66-year-old female with history of thighbone pain and spontaneous femoral fracture, osteolytic lesions, hypercalcemia, elevated levels of alkaline phosphatase and parathyroid hormone detected; the scintigraphy showed a functioning tumor located in upper mediastinum. By hemithyroidectomy in block, the tumor was resected. Histopathological study reported parathyroid carcinoma. Discussion: PC is the least common neoplasia, in patients with parathyroid hormone levels greater than 1,000 pg/ml and hypercalcemia upper of 14 mg/dl this disease should be suspected.


REFERENCES

  1. Schaapveld M, Jorna FH, Aben KK, Haak HR, Plukker JT, Links TP. Incidence and prognosis of parathyroid gland carcinoma: A population-based study in The Netherlands estimating the preoperative diagnosis. Am J Surg. 2011; 202(5): 590-7.

  2. De Quervain VF. Parastruma maligna aberrata. Deut Zschr Chir. 1909; 100: 334-52.

  3. Armstrong HG. Primary carcinoma of the parathyroid with report of a case. Bull Acad Med Tor. 1938; 11: 105-10.

  4. Busaidy NL, Jimenez C, Habra MA, Schultz PN, El-Naggar AK, Clayman GL, et al. Parathyroid carcinoma: a 22-year experience. Head Neck. 2004; 26(8): 716-26.

  5. Haven CJ, Van Puijenbroek M, Tan MH, Teh BT, Fleuren GJ, Van Wezel T, et al. Identification of MEN1 and HRPT2 somatic mutations in paraffin-embedded (sporadic) parathyroid carcinomas. Clin Endocrinol (Oxf). 2007; 67(3): 370-6.

  6. Hundahl SA, Fleming ID, Fremgen AM, Menck HR. Two hundred eighty-six cases of parathyroid carcinoma treated in the U.S. Between 1985-1995: a National Cancer Data Base Report. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer. 1999; 86(3): 538-44.

  7. Karakas E, Müller HH, Lyadov VK, Luz S, Schneider R, Rothmund M, et al. Development of a formula to predict parathyroid carcinoma in patients with primary hyperparathyroidism. World J Surg. 2012; 36(11): 2605-11.

  8. Wynne AG, Van Heerden J, Carney JA, Fitzpatrick LA. Parathyroid carcinoma: clinical and pathologic features in 43 patients. Medicine (Baltimore). 1992; 71(4): 197-205.

  9. Talat N, Schulte KM. Clinical presentation, staging and long-term evolution of parathyroid cancer. Ann Surg Oncol. 2010; 17(8): 2156-74.

  10. Fang SH, Lal G. Parathyroid cancer. Endocr Pract. 2011; 17(Suppl 1): 36-43.

  11. Bergero N, De Pompa R, Sacerdote C, Gasparri G, Volante M, Bussolati G, et al. Galectin-3 expression in parathyroid carcinoma: immunohistochemical study of 26 cases. Hum Pathol. 2005; 36(8): 908-14.

  12. Schulte KM, Talat N, Miell J, Moniz C, Sinha P, Diaz-Cano S. Lymph node involvement and surgical approach in parathyroid cancer. World J Surg. 2010; 34(11): 2611-20.

  13. Lim S, Elston MS, Gill AJ, Marsh DJ, Conaglen JV. Metastatic parathyroid carcinoma initially misdiagnosed as parathyroid adenoma: the role of parafibromin in increasing diagnostic accuracy. Intern Med J. 2011; 41(9): 695-9.

  14. Schulte KM, Gill AJ, Barczynski M, Karakas E, Miyauchi A, Knoefel WT, et al. Classification of parathyroid cancer. Ann Surg Oncol. 2012; 19: 2620-8.




2020     |     www.medigraphic.com